Tacrolimus Toxicity due to Biliary Obstruction in a Combined Kidney and Liver Transplant Recipient
The immunosuppressant tacrolimus has a narrow therapeutic window, necessitating therapeutic drug monitoring to maintain efficacy and minimise toxicity. There are very few reports examining the impact of impaired biliary excretion on tacrolimus blood levels or toxicity. We report the case of a 26-yea...
Saved in:
Main Authors: | Samuel Chan, Michael T. Burke, David W. Johnson, Ross S. Francis, David W. Mudge |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Transplantation |
Online Access: | http://dx.doi.org/10.1155/2017/9096435 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The association between serum tacrolimus concentrations and BK viruria in kidney transplant recipients
by: Napatsorn Kraivisitkul, et al.
Published: (2025-01-01) -
Tacrolimus toxicity management in a pregnant kidney transplant recipient with newly diagnosed human immunodeficiency virus: A case report
by: Ahmad Matarneh, et al.
Published: (2025-02-01) -
Switching Stable Kidney Transplant Recipients to a Generic Tacrolimus Is Feasible and Safe, but It Must Be Monitored
by: Fernando González, et al.
Published: (2017-01-01) -
Tacrolimus- and Mycophenolate-Mediated Toxicity: Clinical Considerations and Options in Management of Post-Transplant Patients
by: Alan D. Kaye, et al.
Published: (2024-12-01) -
Tacrolimus trough level and oxidative stress in Tunisian kidney transplanted patients
by: Mariam Ammar, et al.
Published: (2024-12-01)